Challenges and opportunities in insomnia disorder

References

• Institute of Medicine. Sleep disorders and sleep deprivation: an unmet public health problem. Washington (DC): National Academies Press (US); 2006.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Impact of the DSM-IV to DSM-5 changes on the national survey on drug use and health. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2016.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): APA; 2013.
   Google Scholar
• Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394.
   PubMed Web of Science ®Google Scholar
• Benjamins JS, Migliorati F, Dekker K, et al. Insomnia heterogeneity: characteristics to consider for data-driven multivariate subtyping. Sleep Med Rev. 2017;36:71–81.
   PubMed Web of Science ®Google Scholar
• Thorpy MJ. Classification of sleep disorders. Neurotherapeutics. 2012;9(4):687–701.
   PubMed Web of Science ®Google Scholar
• Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract. 2002;51(3):229–235.
   PubMed Web of Science ®Google Scholar
• Javaheri S, Redline S. Insomnia and risk of cardiovascular disease. Chest. 2017;152(2):435–444.
   PubMed Web of Science ®Google Scholar
• Alshehri MM, Alenazi AM, Hoover JC, et al. Effect of cognitive behavioral therapy for insomnia on insomnia symptoms for individuals with type 2 diabetes: protocol for a pilot randomized controlled trial. JMIR Res Protoc. 2019;8(12):e14647–e.
   PubMed Web of Science ®Google Scholar
• Shan Z, Ma H, Xie M, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Dia Care. 2015;38(3):529–537.
   PubMed Web of Science ®Google Scholar
• Lovato N, Lack L. Insomnia and mortality: a meta-analysis. Sleep Med Rev. 2019;43:71–83..
   PubMed Web of Science ®Google Scholar
• Saddichha S. Diagnosis and treatment of chronic insomnia. Ann Indian Acad Neurol. 2010;13(2):94–102.
   PubMed Web of Science ®Google Scholar
• Grandner MA, Alfonso-Miller P, Fernandez-Mendoza J, et al. Sleep: important considerations for the prevention of cardiovascular disease. Curr Opin Cardiol. 2016;31(5):551–565.
   PubMed Web of Science ®Google Scholar
• Harvey AG, Tang N. (Mis)perception of sleep in insomnia: a puzzle and a resolution. Psychol Bull. 2012; 138(1):77–101.
   PubMed Web of Science ®Google Scholar
• Jungwirth S, Fischer P, Weissgram S, et al. Subjective memory complaints and objective memory impairment in the Vienna-transdanube aging community. J Am Geriatr Soc. 2004;52(2):263–268.
   PubMed Web of Science ®Google Scholar
• Tsapanou A, Vlachos GS, Cosentino S, et al. Sleep and subjective cognitive decline in cognitively healthy elderly: Results from two cohorts. J Sleep Res. 2019;28(5):e12759.
   PubMed Web of Science ®Google Scholar
• Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, et al. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev. 2012;16(1):83–94.
   PubMed Web of Science ®Google Scholar
• Cross NE, Carrier J, Postuma RB, et al. Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on aging. Sleep. 2019;42(8):zsz114.
   PubMed Web of Science ®Google Scholar
• Laugsand LE, Strand LB, Vatten LJ, et al. Insomnia symptoms and risk for unintentional fatal injuries-the HUNT Study. Sleep. 2014;37(11):1777–1786.
   PubMed Web of Science ®Google Scholar
• Stone KL, Ensrud KE, Ancoli-Israel S. Ancoli-Israel S. Sleep, insomnia and falls in elderly patients. Sleep Med. 2008;9(Suppl 1):S18–S22.
   PubMed Web of Science ®Google Scholar
• Shahly V, Berglund PA, Coulouvrat C, et al. The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. Arch Gen Psychiatry. 2012;69(10):1054–1063.
   PubMed Web of Science ®Google Scholar
• Wickwire EM, Shaya FT, Scharf SM. Health economics of insomnia treatments: the return on investment for a good night's sleep. Sleep Med Rev. 2016;30:72–82.
   PubMed Web of Science ®Google Scholar
• Hom MA, Hames JL, Bodell LP, et al. Investigating insomnia as a cross-sectional and longitudinal predictor of loneliness: findings from six samples. Psychiatry Res. 2017;253:116–128.
   PubMed Web of Science ®Google Scholar
• Roberts RE, Ramsay Roberts C, Ger Chen I. Impact of insomnia on future functioning of adolescents. J Psychosom Res. 2002;53(1):561–569..
   PubMed Web of Science ®Google Scholar
• Chu C, Hom MA, Gallyer AJ, et al. Insomnia predicts increased perceived burdensomeness and decreased desire for emotional support following an in-laboratory social exclusion paradigm. J Affect Disord. 2019;243:432–440.
   PubMed Web of Science ®Google Scholar
• Knutson KL, Phelan J, Paskow MJ, et al. The National sleep foundation’s sleep health index. Sleep Health. 2017;3(4):234–240.
   PubMed Web of Science ®Google Scholar
• Hing EC, Woodwell DA. National ambulatory medical care survey: 2004 summary. Adv Data. 2006;2006(374):1–33.
   Google Scholar
• Sorscher AJ. How is your sleep: a neglected topic for health care screening. J Am Board Fam Med. 2008;21(2):141–148.
   PubMed Web of Science ®Google Scholar
• Grandner MA, Chakravorty S. Insomnia in primary care: misreported, mishandled, and just plain missed. J Clin Sleep Med. 2017;13(8):937–939.
   PubMed Web of Science ®Google Scholar
• J. Klingman K, R. Jungquist C, L. Perlis M. Introducing the sleep disorders symptom checklist-25: a primary care friendly and comprehensive screener for sleep disorders. Sleep Med Res. 2017;8(1):17–25.
   Google Scholar
• Papp KK, Penrod CE, Strohl KP. Knowledge and attitudes of primary care physicians toward sleep and sleep disorders. Sleep Breath. 2002;6(3):103–109.
   PubMedGoogle Scholar
• Ulmer CS, Bosworth HB, Beckham JC, et al. Veterans affairs primary care provider perceptions of insomnia treatment. J Clin Sleep Med. 2017;13(8):991–999.
   PubMed Web of Science ®Google Scholar
• Mai E, Buysse DJ. Insomnia: prevalence, impact, pathogenesis, differential diagnosis, and evaluation. Sleep Med Clin. 2008;3(2):167–174.
   PubMedGoogle Scholar
• Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the american college of physicians. Ann Intern Med. 2016;165(2):125–133.
   PubMed Web of Science ®Google Scholar
• Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700.
   PubMed Web of Science ®Google Scholar
• Mitchell MD, Gehrman P, Perlis M, et al. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012;13:40.
   PubMed Web of Science ®Google Scholar
• Trauer JM, Qian MY, Doyle JS, et al. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med. 2015;163(3):191–204.
   PubMed Web of Science ®Google Scholar
• Kyle SD, Miller CB, Rogers Z, et al. Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. Sleep. 2014;37(2):229–237.
   PubMed Web of Science ®Google Scholar
• Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307–349.
   PubMed Web of Science ®Google Scholar
• Williams J, Roth A, Vatthauer K, et al. Cognitive behavioral treatment of insomnia. Chest. 2013;143(2):554–565.
   PubMed Web of Science ®Google Scholar
• Koffel E, Bramoweth AD, Ulmer CS. Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review. J Gen Intern Med. 2018;33(6):955–962.
   PubMed Web of Science ®Google Scholar
• Zachariae R, Lyby MS, Ritterband LM, et al. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia - a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2016;30:1–10.
   PubMed Web of Science ®Google Scholar
• Troxel WM, Germain A, Buysse DJ. Clinical management of insomnia with brief behavioral treatment (BBTI). Behav Sleep Med. 2012; 10(4):266–279.
   PubMed Web of Science ®Google Scholar
• Baglioni C, Altena E, Bjorvatn B, et al. The European Academy for Cognitive Behavioural Therapy for Insomnia: an initiative of the European Insomnia Network to promote implementation and dissemination of treatment. J Sleep Res. 2020;29(2):e12967.
   PubMed Web of Science ®Google Scholar
• Longo LP, Johnson B. Addiction: Part I. Benzodiazepines–side effects, abuse risk and alternatives. Am Fam Phys. 2000;61(7):2121–2128.
   PubMed Web of Science ®Google Scholar
• Wagner J, Wagner ML. Non-benzodiazepines for the treatment of insomnia. Sleep Med Rev. 2000;4(6):551–581..
   PubMed Web of Science ®Google Scholar
• Agravat A. Z’-hypnotics versus benzodiazepines for the treatment of insomnia. Prog Neurol Psychiatry. 2018;22(2):26–29.
   Web of Science ®Google Scholar
• Brandt J, Leong C. Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R D. 2017;17(4):493–507.
   PubMed Web of Science ®Google Scholar
• Dündar Y, Dodd S, Strobl J, et al. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol. 2004;19(5):305–322.
   PubMed Web of Science ®Google Scholar
• US Food & Drug Administration. FDA adds boxed warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines. FDA Drug Safety Communication; 2019. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-risk-serious-injuries-caused-sleepwalking-certain-prescription-insomnia.
   Google Scholar
• American Geriatrics Society 2019. Updated AGS beers criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694.
   PubMed Web of Science ®Google Scholar
• Guina J, Merrill B. Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives. JCM. 2018;7(2):17.
   Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Prescription drug use and misuse in the United States: results from the 2015 National Survey on Drug Use and Health. 2016. Available from: https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR2-2015/NSDUH-FFR2-2015.pdf.
   Google Scholar
• Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs. 2003;17(11):825–837.
   PubMed Web of Science ®Google Scholar
• Puustinen J, Lähteenmäki R, Polo-Kantola P, et al. Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults. Eur J Clin Pharmacol. 2014;70(3):319–329.
   PubMed Web of Science ®Google Scholar
• Fluyau D, Revadigar N, Manobianco BE. Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation. Ther Adv Psychopharmacol. 2018;8(5):147–168.
   PubMed Web of Science ®Google Scholar
• Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007;22(9):1335–1350.
   PubMed Web of Science ®Google Scholar
• Holbrook AM, Crowther R, Lotter A, et al. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 2000;162(2):225–233.
   PubMed Web of Science ®Google Scholar
• Krone L, Frase L, Piosczyk H, et al. Top-down control of arousal and sleep: fundamentals and clinical implications. Sleep Med Rev. 2017;31:17–24.
   PubMed Web of Science ®Google Scholar
• Provencher T, Charest J, Bastien CH. Non-invasive brain stimulation for insomnia - a review of current data and future implications. OBM ICM. 2019;5(1):1.
   Google Scholar
• Saebipour MR, Joghataei MT, Yoonessi A, et al. Slow oscillating transcranial direct current stimulation during sleep has a sleep-stabilizing effect in chronic insomnia: a pilot study. J Sleep Res. 2015; 24(5):518–525.
   PubMed Web of Science ®Google Scholar
• Wiegand MH. Antidepressants for the Treatment of insomnia: a suitable approach? Drugs. 2008;68(17):2411–2417.
   PubMed Web of Science ®Google Scholar
• Walsh JK. Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine. Sleep. 2004;27(8):1441–1442.
   PubMed Web of Science ®Google Scholar
• Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci. 2017;14(7–8):24–34.
   PubMedGoogle Scholar
• Haario P, Rahkonen O, Laaksonen M, et al. Bidirectional associations between insomnia symptoms and unhealthy behaviours. J Sleep Res. 2013;22(1):89–95.
   PubMed Web of Science ®Google Scholar
• Angarita GA, Emadi N, Hodges S, et al. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract. 2016;11(1):9.
   PubMedGoogle Scholar
• Everitt H, Baldwin DS, Stuart B, et al. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018;5(5):CD010753.
   PubMed Web of Science ®Google Scholar
• Minkel J, Krystal AD. Optimizing the pharmacologic treatment of insomnia: current status and future horizons. Sleep Med Clin. 2013;8(3):333–350.
   PubMedGoogle Scholar
• Wilson S, Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs. 2005;65(7):927–947.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan K, Scheid D. Treatment options for insomnia. Am Fam Physician. 2007;76(4):517–526.
   PubMed Web of Science ®Google Scholar
• Lie JD, Tu KN, Shen DD, et al. Pharmacological treatment of insomnia. P T. 2015;40(11):759–771.
   PubMedGoogle Scholar
• Richardson GS, Roehrs TA, Rosenthal L, et al. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol. 2002;22(5):511–515.
   PubMed Web of Science ®Google Scholar
• American Academy of Sleep Medicine. New clinical practice guideline for the pharmacologic treatment of chronic insomnia. 2017.
   Google Scholar
• US Department of Health and Human Services. National Institutes of Health HEAL Initiative: Research. 2019. Available from: https://heal.nih.gov/research.
   Google Scholar